BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 3032413)

  • 1. Determinants of complete remission induction and maintenance in chemotherapy with or without irradiation of small cell lung cancer.
    Osterlind K; Hansen HH; Dombernowsky P; Hansen M; Andersen PK
    Cancer Res; 1987 May; 47(10):2733-6. PubMed ID: 3032413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation.
    Osterlind K; Andersen PK
    Cancer Res; 1986 Aug; 46(8):4189-94. PubMed ID: 3015384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J; Whitacre M; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
    J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
    Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to multimodal treatment in advanced neuroblastomas. Factors associated with complete remission induction, and factors associated with prolonged survival.
    Carlsen NL; Schroeder H; Bro PV; Hesselbjerg U; Jensen KB; Nielsen OH; Hertz H; Johansen H; Pedersen SA; Walbom-Jørgensen S
    Anticancer Res; 1989; 9(4):837-44. PubMed ID: 2817811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
    Kamath SS; McCarley DL; Zlotecki RA
    Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined modality treatment of small cell carcinoma of the lung.
    Feld R; Pringle JF; Evans WK; Keen CW; Quirt IC; Curtis JE; Baker MA; Yeoh JL; Deboer G; Brown TC
    Arch Intern Med; 1981 Mar; 141(4):469-73. PubMed ID: 6260048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiotherapy of limited pulmonary microcytoma in current clinical practice].
    Pirtoli L; Bellezza A; Tucci E; Pepi F; Crociani M; Crastolla AM; Farzad M; Sebaste L; Bindi M
    Radiol Med; 1994 Dec; 88(6):863-8. PubMed ID: 7533305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
    Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
    Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial.
    Gatzemeier U; Pawel JV; Laumen R; Hossfeld DK; Neuhauss R
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):31-5. PubMed ID: 8052871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
    Hainsworth JD; Stroup SL; Greco FA
    Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
    J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.